Rivastigmine
Back to searchMolecule Structure
Scientific Name
Rivastigmine
Description of the Drug
Rivastigmine is a cholinesterase inhibitor used to treat mild to moderate dementia in Alzheimer’s and Parkinson’s.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00989
http://www.drugbank.ca/drugs/DB00989
Brand Name(s)
Alzest, Eluden, Erastig, Exelon, Kerstipon, Nimvastid, Prometax, Rivastigmine, Somniton, Voleze
Company Owner(s)
Apotex Inc, Alembic Pharmaceuticals Ltd, Amneal Pharmaceuticals Of New York Llc, Macleods Pharmaceuticals Ltd, Alvogen Inc, Watson Laboratories Inc, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Dr Reddys Laboratories Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cholinesterases; ACHE & BCHE | SELECTIVITY GROUP | INHIBITOR | CHEMBL2095233 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2764 | ||
PharmGKB | PA451262 | ||
Human Metabolome Database | HMDB0015124 | ||
DrugBank | DB00989 | ||
PubChem: Thomson Pharma | 15122215 | 14774320 | |
PubChem | 77991 | ||
LINCS | LSM-5280 | ||
Nikkaji | J982.502I | ||
BindingDB | 11682 | 10620 | |
EPA CompTox Dashboard | DTXSID7023564 | ||
DrugCentral | 2392 | ||
Brenda | 231326 | 117556 | |
ChemicalBook | CB92656938 | ||
Guide to Pharmacology | 6602 | ||
rxnorm | RIVASTIGMINE | EXELON | RIVASTIGMINE TARTRATE |
KEGG Ligand | C11766 | ||
ChEBI | 8874 | ||
ZINC | ZINC000000004413 |